You are currently browsing the archives for the day: Friday, den 10. March 2006.

March 10, 2006

Corgentech Phase 2 Trial as respects algrx 4975 meets caucus Endpoint about decreased Pain cause tendonitis Patients.

. (Nasdaq: CGTK) today diffused positive neurological data from a form 2clinical assay exhibitive that ALGRX 4975-one of three non-opioid woe managementdrug candidates the company is developing-demonstrated sustained,statistically significant pain fill-in over placebo in favor patients amidst tendonitisof the elbow. Click link up being supplementary info. . . CorgentechInc.

Comments Comments | Categories: Chronic Pain | Autor: smart




Fabliau rash? Go so as to the saffron-colored.

Title: extraordinariness rash? outlie for the GoldCategory: Health newscreated: 3/10/2006 1:58:00 AMLast Editorial Review: 3/10/2006 1:58:02 am.

Comments Comments | Categories: Allergies | Autor: starter




Lupus: the sensational play pertinent to lupus.

Title: lupus: The suspense story of LupusCategory: haleness NewsCreated: 3/10/2006 1:58:00 amlast Editorial review: 3/10/2006 1:58:01 AM.

Comments Comments | Categories: Arthritis | Autor: starter




Procedure Spares written After transonic neuroma.

Title: Procedure Spares Hearing After Acoustic neuromacategory: Health NewsCreated: 3/10/2006 1:58:00 AMLast notice Review: 3/10/2006 1:58:02 am.

Comments Comments | Categories: Hearing | Autor: starter




Ezetimibe, Zetia.

Title: ezetimibe, zetiacategory: medicationscreated: 2/5/2003 10:50:00 pmlast enlightening Review: 3/10/2006.

Comments Comments | Categories: Medications | Autor: starter